DT388IL3 fusion protein
Term · Oncology and biomedicine · MLC-T-ONC-002600
A substance being studied in the treatment of myeloid leukemia (a disease in which too many immature non-lymphocyte white blood cells are found in the blood and bone marrow). DT388IL3 fusion protein is made by combining IL-3 with a toxic substance. The IL-3 attaches to the cancer cells and the toxic substance kills them.
| Identifier | MLC-T-ONC-002600 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002600",
"term": "DT388IL3 fusion protein",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of myeloid leukemia (a disease in which too many immature non-lymphocyte white blood cells are found in the blood and bone marrow). DT388IL3 fusion protein is made by combining IL-3 with a toxic substance. The IL-3 attaches to the cancer cells and the toxic substance kills them.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/dt388il3-fusion-protein/"
}
Record 6,263 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.